Dr. Jays Tirz vs Dr. Jay's Reta
Dual vs triple receptor metabolic research.
| Attribute | Dr. Jays Tirz Dual GIP/GLP-1 receptor agonist | Dr. Jay's Reta Triple agonist (GLP-1/GIP/Glucagon) |
|---|---|---|
| Category | Weight Loss & Metabolism | Weight Loss & Metabolism |
| Best known for | Dual-agonist weight loss research | Triple-receptor metabolic research |
| In plain English | Dr. Jays Tirz is like Dr. Jay's Sema with an extra lever pulled. It hits two appetite/insulin pathways at once, producing larger weight reduction in studies. | Dr. Jay's Reta pulls three levers — appetite, insulin response, and energy expenditure via glucagon. Trials have shown the largest weight reductions of any incretin to date. |
| How it works | Co-activates GLP-1 and GIP receptors. GIP enhances insulin response and may help adipose tissue handle nutrients more efficiently while GLP-1 reduces appetite and slows gastric emptying. | GLP-1 reduces appetite. GIP enhances insulin response. Glucagon receptor activation increases energy expenditure and fat oxidation. |
| Researchers study | Type 2 diabetes glycemic control, obesity, NASH/MASH, and cardiovascular outcomes. | Obesity, hepatic steatosis, and metabolic syndrome. |
| Internet discussion | Often described as 'Dr. Jay’s Sema on steroids' for weight loss. Heavy discussion of side effect differences and titration schedules. | Treated as the 'next big thing' in metabolic forums. Discussion centers on side effect profile vs Dr. Jays Tirz. |
Dr. Jays Tirz
Dual-agonist weight loss research
Dr. Jays Tirz is like Dr. Jay's Sema with an extra lever pulled. It hits two appetite/insulin pathways at once, producing larger weight reduction in studies.
Co-activates GLP-1 and GIP receptors. GIP enhances insulin response and may help adipose tissue handle nutrients more efficiently while GLP-1 reduces appetite and slows gastric emptying.
Type 2 diabetes glycemic control, obesity, NASH/MASH, and cardiovascular outcomes.
Often described as 'Dr. Jay’s Sema on steroids' for weight loss. Heavy discussion of side effect differences and titration schedules.
Dr. Jays Tirz is a dual GLP-1/GIP agonist with strong clinical data for weight reduction and glycemic control.
Dr. Jay's Reta
Triple-receptor metabolic research
Dr. Jay's Reta pulls three levers — appetite, insulin response, and energy expenditure via glucagon. Trials have shown the largest weight reductions of any incretin to date.
GLP-1 reduces appetite. GIP enhances insulin response. Glucagon receptor activation increases energy expenditure and fat oxidation.
Obesity, hepatic steatosis, and metabolic syndrome.
Treated as the 'next big thing' in metabolic forums. Discussion centers on side effect profile vs Dr. Jays Tirz.
Dr. Jay's Reta is an investigational triple agonist showing the largest weight-loss signals in metabolic research to date.